FDA Approved: VAFSEO — Original Application (Akebia Therapeutics, Inc.)

View source ↗

Summary

The FDA approved VAFSEO (vadadustat) under an original NDA from Akebia Therapeutics for the treatment of anemia due to chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia Due to Chronic Kidney Disease

Drugs mentioned

• VAFSEO (VADADUSTAT)

Snippet

ORIG AP for VAFSEO (VADADUSTAT)